Adaptimmune Therapeutics shares owned by Carmichael Hill & Associates
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Carmichael Hill & Associates
from 13F filings
Historical chart of Carmichael Hill & Associates investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Carmichael Hill & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Carmichael Hill & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $830 | 525 | 1.58 |
| 2023-12-31 | $417 | 525 | 0.79 |
| 2023-09-30 | $410 | 525 | 0.78 |
| 2023-06-30 | $485 | 525 | 0.93 |
| 2023-03-31 | $572 | 525 | 1.09 |
| 2022-12-31 | $765 | 525 | 1.46 |
| 2022-09-30 | $1.0k | 525 | 1.90 |
| 2022-06-30 | $1.0k | 525 | 1.90 |
| 2022-03-31 | $1.0k | 525 | 1.90 |
| 2021-12-31 | $999 | 350 | 2.86 |
| 2021-09-30 | $999 | 210 | 4.76 |
| 2021-06-30 | $999 | 210 | 4.76 |
| 2021-03-31 | $999 | 120 | 8.33 |
| 2020-12-31 | $999 | 120 | 8.33 |
| 2020-09-30 | $0 | 40 | 0.00 |
More positions owned by Carmichael Hill & Associates
View all positions for Carmichael Hill & Associates